Micheline Wehbe - Infectious Diseases

Author Information

Michel Wehbe is affiliated with the WHO Collaborating Center for Reference and Research on Bacterial Pathogens at the Center for Infectious Diseases Research (CIDR), Faculty of Medicine, American University of Beirut, located in Beirut, Lebanon. His research is primarily within the field of infectious diseases, contributing significantly to our understanding of viral infections and immune responses.

Research Contributions

Michel Wehbe has made substantial contributions to the field of infectious diseases, particularly focusing on viral infections and the immune system's response to these pathogens. His work includes research on antimicrobial peptides produced by human keratinocytes, the persistence of enterovirus in cardiac cells, and the immune response to Zika and flaviviral infections. His research also extends to the study of Mycobacterium tuberculosis using advanced spoligotyping methods and the development of tools to assess viral replication in enterovirus strains. His earlier work includes studies on vaccine trials for bovine mastitis and the effects of fire on soil properties in Lebanon.

Aliases

Michel Wehbe is also known by the alias Micheline Wehbe. This alternative name has appeared in various publications and professional contexts.

Publication and Citation Metrics

Metric	Value
Total Papers	10
Total Citations	155
h-index	4

Publications:

Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes

DOI: 10.3389/fmicb.2020.01155

Year: 2020

Spoligotyping of Mycobacterium tuberculosis isolates using Luminex®-based method in Lebanon.

DOI: 10.3855/jidc.12072

Year: 2020

Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.

DOI: 10.1161/CIRCULATIONAHA.118.035966

Year: 2019

Innate immunity against Zika virus

DOI: 10.1097/MRM.0000000000000112

Year: 2017

Skin innate immune response to flaviviral infection

DOI: 10.1684/ecn.2017.0394

Year: 2017

Construction of a subgenomic CV-B3 replicon expressing emerald green fluorescent protein to assess viral replication of a cardiotropic enterovirus strain in cultured human cells.

DOI: 10.1016/j.jviromet.2016.01.005

Year: 2016

Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues

DOI: 10.3201/eid2208.160186

Year: 2016

Effect of fire on soil properties beneath Quercus calliprinos in Lebanon ant its impact on regeneration and leave components

DOI:

Year: 2013

Field trials of a vaccine against bovine mastitis. 2. Evaluation in two commercial dairy herds.

DOI: 10.3168/JDS.S0022-0302(97)76007-7

Year: 1997

How Do Respiratory Droplets Spread Diseases?

Are Decongestants Safe?

What Future Directions is the NIH Taking in Infectious Disease Research?

How Do Neuraminidase Inhibitors Work?

Who Should Receive Antiviral Treatment?

How Can Bacterial Infections Be Prevented?

What Role Does the FDA Play in Diagnostic Testing?

How Does Artemisinin Work?

How do Infectious Diseases Spread?

How is Avian Influenza Transmitted?

Partnered Content Networks

Relevant Topics